New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 31, 2012
09:00 EDTDGXQuest Diagnostics sells OralDNA labs to Access Genetics
Quest Diagnostics announced that it has sold substantially all of the assets of its OralDNA(R) Labs salivary-diagnostics business to Access Genetics, a clinical laboratory with advanced molecular diagnostics test development and information technology capabilities. Terms of the transaction were not disclosed.
News For DGX From The Last 14 Days
Check below for free stories on DGX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
07:08 EDTDGXLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use